|
1
|
Huggins C and Hodges CV: Studies on
prostatic cancer. I. The effect of castration, of estrogen and of
androgen injection on serum phosphatases in metastatic carcinoma of
the prostate. Cancer Res. 1:293–297. 1941.
|
|
2
|
Emmett JL, Green LF and Papantoniou A:
Endocrine therapy in carcinoma of the prostate gland: 10-year
survival studies. J Urol. 83:471–484. 1960.
|
|
3
|
Shiina H, Igawa M and Ishibe T:
Estramustine-binding protein to dihydrotestosterone ratio in human
prostatic carcinoma: a new marker for predicting disease
progression. Br J Urol. 77:96–101. 1996. View Article : Google Scholar
|
|
4
|
Shiina H, Igawa M and Ishibe T: Clinical
study on estramustine binding protein (EMBP) in human prostate.
Prostate. 29:169–176. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Iguchi K, Otsuka T, Usui S, Ishii K,
Onishi T, Sugimura Y and Hirano K: Zinc and metallothionein levels
and expression of zinc transporters in androgen-independent subline
of LNCaP cells. J Androl. 25:154–161. 2004.PubMed/NCBI
|
|
6
|
Hidalgo J, Chung R, Penkowa M and Vašák M:
Structure and function of vertebrate metallothioneins. In:
Metallothioneins and Related Chelators. Sigel A, Sigel H and Sigel
RKO: The Royal Society of Chemistry; Cambridge: pp. 279–317.
2009
|
|
7
|
Garrett SH, Sens MA, Shukla D, Nestor S,
Somji S, Todd JH and Sens DA: Metallothionein isoform 3 expression
in the human prostate and cancer-derived cell lines. Prostate.
41:196–202. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hasumi M, Suzuki K, Matsui H, Koike H, Ito
K and Yamanaka H: Regulation of metallothionein and zinc
transporter expression in human prostate cancer cells and tissues.
Cancer Lett. 200:187–195. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Henshall SM, Afar DE, Rasiah KK, Horvath
LG, Gish K, Caras I, Ramakrishnan V, Wong M, Jeffry U, Kench JG,
Quinn DI, Turner JJ, Delprado W, Lee CS, Golovsky D, Brenner PC,
O'Neill GF, Kooner R, Stricker PD, Grygiel JJ, Mack DH and
Sutherland RL: Expression of the zinc transporter ZnT4 is decreased
in the progression from early prostate disease to invasive prostate
cancer. Oncogene. 22:6005–6012. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rishi I, Baidouri H, Abbasi JA,
Bullard-Dillard R, Kajdacsy-Balla A, Pestaner JP, Skacel M, Tubbs R
and Bagasra O: Prostate cancer in African American men is
associated with downregulation of zinc transporters. Appl
Immunohistochem Mol Morphol. 11:253–260. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Iguchi K, Hamatake M, Ishida R, Usami Y,
Adachi T, Yamamoto H, Koshida K, Uchibayashi T and Hirano K:
Induction of necrosis by zinc in prostate carcinoma cells and
identification of proteins increased in association with this
induction. Eur J Biochem. 253:766–770. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ishii K, Usui S, Sugimura Y, Yoshida S,
Hioki T, Tatematsu M, Yamamoto H and Hirano K: Aminopeptidase N
regulated by zinc in human prostate participates in tumor cell
invasion. Int J Cancer. 92:49–54. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ishii K, Otsuka T, Iguchi K, Usui S,
Yamamoto H, Sugimura Y, Yoshikawa K, Hayward SW and Hirano K:
Evidence that the prostate-specific antigen
(PSA)/Zn2+axis may play a role in human prostate cancer
cell invasion. Cancer Lett. 207:79–87. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Iguchi K, Ishii K, Nakano T, Otsuka T,
Usui S, Sugimura Y and Hirano K: Isolation and characterization of
LNCaP sublines differing in hormone sensitivity. J Androl.
28:670–678. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Verrijdt G, Haelens A and Claessens F:
Selective DNA recognition by the androgen receptor as a mechanism
for hormone-specific regulation of gene expression. Mol Genet
Metab. 78:175–185. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Belloso E, Hernandez J, Giralt M, Kille P
and Hidalgo J: Effect of stress on mouse and rat brain
metallothionein I and III mRNA levels. Neuroendocrinology.
64:430–439. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Moffatt P and Séguin C: Expression of the
gene encoding metallothionein-3 in organs of the reproductive
system. DNA Cell Biol. 17:501–510. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wei H, Desouki MM, Lin S, Xiao D, Franklin
RB and Feng P: Differential expression of metallothioneins (MTs) 1,
2, and 3 in response to zinc treatment in human prostate normal and
malignant cells and tissues. Mol Cancer. 7:72008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cyr DG, Dufresne J, Pillet S, Alfieri TJ
and Hermo L: Expression and regulation of metallothioneins in the
rat epididymis. J Androl. 22:124–135. 2001.PubMed/NCBI
|
|
20
|
Iguchi K, Morihara N, Usui S, Hayama M,
Sugimura Y and Hirano K: Castration- and aging-induced changes in
the expression of zinc transporter and metallothionein in rat
prostate. J Androl. 32:144–150. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dutta R, Sens DA, Somji S, Sens MA and
Garrett SH: Metallothionein isoform 3 expression inhibits cell
growth and increases drug resistance of PC-3 prostate cancer cells.
Prostate. 52:89–97. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gurel V, Sens DA, Somji S, Garrett SH,
Nath J and Sens MA: Stable transfection and overexpression of
metallothionein isoform 3 inhibits the growth of MCF-7 and Hs578T
cells but not that of T-47D or MDA-MB-231 cells. Breast Cancer Res
Treat. 80:181–191. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang B, Wood IS and Trayhurn P: PCR arrays
identify metallothionein-3 as a highly hypoxia-inducible gene in
human adipocytes. Biochem Biophys Res Commun. 368:88–93. 2008.
View Article : Google Scholar : PubMed/NCBI
|
